ZIOPHARM Oncology competitorsClear all

ZIOPHARM Oncology's top competitors include Circuit Therapeutics, OXGENE, Kolon TissueGene and Angiocrine Bioscience.
ZIOPHARM Oncology
ZIOPHARM Oncology
ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.
Circuit Therapeutics
Circuit Therapeutics
Circuit Therapeutics is a biotechnology company driving the discovery and development of neural therapies.
OXGENE
OXGENE
OXGENE (also known as Oxford Genetics) is a synthetic biology company.
Kolon TissueGene
Kolon TissueGene
Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders.
Angiocrine Bioscience
Angiocrine Bioscience
Angiocrine Bioscience is a clinical-stage cell and gene therapy company.
Founding Date
Founding Date
2005
Founding Date
2010
Founding Date
2011
Founding Date
1999
Founding Date
2012
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Boston, US HQ
Locations
Menlo Park, US HQ
Locations
Oxford, GB HQ
Cambridge, US
Locations
Rockville, US HQ
Locations
San Diego, US HQ
Employees
Employees
7352% increase
Employees
1418% decrease
Employees
872% increase
Employees
395% increase
Employees
235% increase
Twitter followers
Twitter followers
N/A
Twitter followers
55
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
107
Alexa Website Rank
Alexa Website Rank
466794
Alexa Website Rank
N/A
Alexa Website Rank
274268
Alexa Website Rank
387527
Alexa Website Rank
290809
Employee Rating
Employee Rating
3.6
Employee Rating
3
Employee Rating
5
Employee Rating
1.7
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$146k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
£1m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($53.1m) (FY, 2018)
Net income
N/A
Net income
(£2.7m) (FY, 2018)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 125.1m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 4m
For sources of this data, please see the company profile

View company profiles

Circuit Therapeutics
HQ
Menlo Park, US
Employees
14↓ 18% decrease

Circuit Therapeutics is a biotechnology company driving the discovery and development of neural therapies.

View company
OXGENE
HQ
Oxford, GB
Employees
87↑ 2% increase

OXGENE (also known as Oxford Genetics) is a synthetic biology company.

View company
Kolon TissueGene
HQ
Rockville, US
Employees
39↑ 5% increase

Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders.

View company
Angiocrine Bioscience
HQ
San Diego, US
Employees
23↑ 5% increase

Angiocrine Bioscience is a clinical-stage cell and gene therapy company.

View company